tissu
placenta
sourc
also
notabl
function
differ
furthermor
function
msc
chang
depend
cultur
condit
number
passag
cultur
surfac
stiff
variou
factor
differ
clonal
popul
msc
isol
bonemarrow
aspir
vari
substanti
function
attribut
relat
issu
includ
effect
msc
cryopreserv
continu
complic
use
msc
thu
despit
wealth
data
show
msc
benefici
action
variou
preclin
acut
lung
injuri
model
much
remain
clarifi
exactli
msc
import
potenti
therapeut
action
popul
prepar
msc
might
best
efficaci
given
clinic
situat
becom
increasingli
clear
concept
immunopermiss
inher
use
allogen
msc
accur
msc
stimul
invivo
factor
clinic
administr
express
hla
cellsurfac
molecul
recognis
host
immun
system
newli
evolv
concept
suggest
msc
rapidli
undergo
apoptosi
autophagi
efferocytosi
system
administr
potenti
also
intratrach
administr
despit
abil
msc
releas
paracrin
mediat
host
immun
respons
apoptot
msc
might
also
greatli
shape
action
amelior
inflamm
injuri
context
observ
matthay
colleagu
low
msc
viabil
correl
poor
efficaci
investig
find
support
argument
incorpor
mechanist
hypothesisgener
studi
clinic
investig
continu
ard
howev
remain
viabl
target
mscbase
cell
therapi
need
figur
make
work
respiratori
medicin
four
randomis
trial
extracorpor
membran
oxygen
ecmo
done
patient
sever
acut
respiratori
distress
syndrom
ard
past
year
trial
includ
lungprotect
ventil
strategi
patient
control
group
done
public
us
nation
heart
lung
blood
institut
ard
networksponsor
trial
publish
show
major
reduct
mortal
low
tidal
volum
plateau
pressur
limit
ventil
strategi
sinc
cesar
venoven
ecmo
trial
publish
show
patient
transfer
centr
could
institut
ecmo
significantli
lower
mortal
sever
disabl
month
transfer
ecmo
centr
howev
result
definit
patient
refer
ecmo
centr
receiv
ecmo
evid
patient
control
group
receiv
lungprotect
ventil
recent
trial
eolia
publish
mortal
numer
lower
venoven
ecmo
group
control
group
patient
receiv
lungprotect
ventil
dr
barri
slavenspl
differ
signific
sever
secondari
endpoint
howev
ecmo
significantli
better
control
group
includ
day
aliv
free
need
vasopressor
therapi
renal
replac
therapi
prone
posit
treat
respiratori
failur
decis
stop
eolia
trial
futil
enrol
patient
plan
enrol
patient
base
method
decreas
power
reject
null
hypothesi
might
led
type
error
trial
power
absolut
reduct
mortal
probabl
unrealist
goal
context
uncertainti
interpret
result
eolia
trial
increas
use
ecmo
laveena
munshi
colleagu
report
result
systemat
review
metaanalysi
use
ecmo
adult
patient
sever
ard
issu
lancet
respiratori
medicin
author
includ
three
observ
studi
two
randomis
control
trial
cesar
eolia
three
observ
studi
match
method
use
compar
ecmotr
patient
receiv
ecmo
two
observ
trial
done
primarili
patient
influenza
primari
analysi
restrict
two
randomis
control
trial
patient
overal
show
compar
convent
mechan
ventil
ecmo
associ
reduc
risk
mortal
risk
ratio
rr
ci
ecmo
also
associ
reduc
risk
treatment
failur
defin
death
ecmo
group
death
crossov
ecmo
control
group
metaanalysi
five
studi
includ
patient
overal
ecmo
associ
reduc
risk
mortal
rr
ci
howev
metaanalysi
prone
bia
inclus
observ
studi
includ
randomis
ecmo
treatment
evid
also
suggest
ecmo
associ
risk
major
haemorrhag
munshi
colleagu
conclud
evid
favour
ecmo
moderatetohigh
qualiti
accord
grade
recommend
assess
develop
evalu
criteria
avail
two
randomis
control
trial
metaanalysi
import
limit
unusu
metaanalysi
base
two
randomis
control
trial
author
recognis
limit
tri
adjust
heterogen
trial
despit
limit
metaanalysi
import
contribut
clinician
need
guidanc
interpret
evid
cesar
eolia
although
anoth
trial
ecmo
versu
nonecmo
treatment
sever
acut
respiratori
syndrom
call
trial
like
organis
fund
trial
done
would
complet
mani
year
addit
munshi
colleagu
metaanalysi
goligh
colleagu
done
bayesian
posthoc
analysi
eolia
trial
bayesian
approach
defin
probabl
treatment
effect
rather
rule
absenc
treatment
effect
convent
trial
design
goligh
colleagu
use
sever
estim
posterior
probabl
enthusiasm
sceptic
efficaci
ecmo
patient
sever
ard
bayesian
analysi
show
across
rang
assumpt
probabl
benefit
earli
ecmo
posterior
probabl
mortal
benefit
earli
ecmo
eolia
high
rang
clinic
case
analysi
also
provid
time
exampl
patient
sever
ard
author
analysi
address
question
whether
use
ecmo
clinic
set
provid
pro
con
viewpoint
view
result
eolia
trial
munshi
colleagu
metaanalysi
bayesian
analysi
eolia
clinician
conclud
use
ecmo
patient
sever
ard
import
clinician
certain
institut
therapi
consid
ecmo
includ
optim
lungprotect
ventil
diuresi
neuromuscular
blockad
deep
sedat
prone
posit
possibl
inhal
nitric
oxid
recruit
manoeuvr
renal
replac
therapi
therapi
stabilis
patient
exclus
criteria
eolia
trial
believ
balanc
evid
favour
use
ecmo
sever
ard
avail
medic
centr
experienc
provis
ecmo
eolia
randomis
control
trial
publish
show
signific
differ
prespecifi
primari
endpoint
mortal
extracorpor
membran
oxygen
ecmo
group
control
group
receiv
convent
mechan
ventil
howev
larg
clinic
import
effect
size
note
trial
posthoc
bayesian
analysi
eolia
data
show
high
likelihood
surviv
benefit
ecmo
even
assum
strongli
sceptic
prior
distribut
metaanalysi
publish
lancet
respiratori
medicin
laveena
munshi
colleagu
suggest
ecmo
efficaci
adult
patient
sever
acut
respiratori
distress
syndrom
ard
even
result
clinician
call
anoth
confirmatori
randomis
control
trial
ecmo
ard
although
theoret
appeal
anoth
similar
trial
unlik
studi
would
requir
centr
expert
use
ecmo
view
strong
trend
toward
decreas
mortal
ecmo
group
eolia
mani
experienc
ecmo
practition
would
consid
withhold
ecmo
uneth
patient
sever
ard
inde
even
result
eolia
known
clinic
equipois
problemat
patient
control
group
cross
ecmo
furthermor
enrol
patient
centr
eolia
took
year
anoth
studi
similar
eolia
unlik
complet
definit
clarifi
whether
ecmo
reduc
mortal
sever
ard
inform
mind
ecmo
fit
treatment
algorithm
ard
believ
ecmo
indic
patient
ard
proven
less
invas
strategi
tri
unsuccess
case
ecmoa
highli
invas
resourceintens
techniqueshould
use
without
first
place
patient
prone
posit
inde
approach
use
eolia
trial
unfortun
nonadher
evidencebas
manag
ard
common
highlight
need
critic
care
commun
improv
adopt
proven
therapi
mainli
prone
posit
high
posit
endexpiratori
pressur
strategi
neuromuscular
blockad
also
recommend
strongli
centr
evidencebas
convent
manag
strategi
work
expert
respiratori
failur
centr
optimis
care
transfer
expert
centr
warrant
propos
manag
algorithm
figur
culmin
earli
ecmo
use
intervent
group
eolia
trial
ie
eolia
criteria
met
within
day
invas
mechan
ventil
despit
manag
evidencebas
convent
practic
beyond
use
scenario
ecmo
might
consid
first
term
rescu
ecmo
defin
case
proven
therapi
ard
appliedeg
patient
unstabl
prone
posit
need
rapidli
undergo
ecmo
algorithm
thu
bypass
perceiv
necess
separ
rescu
ecmo
also
describ
use
ecmo
